Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21207199rdf:typepubmed:Citationlld:pubmed
pubmed-article:21207199lifeskim:mentionsumls-concept:C0031268lld:lifeskim
pubmed-article:21207199lifeskim:mentionsumls-concept:C0031001lld:lifeskim
pubmed-article:21207199lifeskim:mentionsumls-concept:C1522564lld:lifeskim
pubmed-article:21207199lifeskim:mentionsumls-concept:C0032743lld:lifeskim
pubmed-article:21207199lifeskim:mentionsumls-concept:C0679622lld:lifeskim
pubmed-article:21207199lifeskim:mentionsumls-concept:C0205314lld:lifeskim
pubmed-article:21207199lifeskim:mentionsumls-concept:C0260193lld:lifeskim
pubmed-article:21207199pubmed:issue2lld:pubmed
pubmed-article:21207199pubmed:dateCreated2011-2-11lld:pubmed
pubmed-article:21207199pubmed:abstractTextMyocardial perfusion imaging is a widely used approach to noninvasively identify myocardial ischemia and guide therapies. It is typically performed using single photon emission computed tomography. The competing technology positron emission tomography (PET) offers higher diagnostic accuracies but suffers from logistical limitations due to the use of short-lived radioisotopes. New (18)F-labeled perfusion markers were introduced in the past years and offer simplified supply approaches, as known from oncologic PET imaging. This review summarizes the available literature especially from preclinical studies, but also very recent findings from early clinical trials. We discuss the consequences of long-lived radioisotopes in myocardial PET and the potential role of absolute blood flow quantification to establish efficient clinical protocols.lld:pubmed
pubmed-article:21207199pubmed:languageenglld:pubmed
pubmed-article:21207199pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21207199pubmed:citationSubsetIMlld:pubmed
pubmed-article:21207199pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21207199pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21207199pubmed:statusMEDLINElld:pubmed
pubmed-article:21207199pubmed:monthAprlld:pubmed
pubmed-article:21207199pubmed:issn1534-3170lld:pubmed
pubmed-article:21207199pubmed:authorpubmed-author:NekollaStepha...lld:pubmed
pubmed-article:21207199pubmed:authorpubmed-author:SarasteAnttiAlld:pubmed
pubmed-article:21207199pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21207199pubmed:volume13lld:pubmed
pubmed-article:21207199pubmed:ownerNLMlld:pubmed
pubmed-article:21207199pubmed:authorsCompleteYlld:pubmed
pubmed-article:21207199pubmed:pagination145-50lld:pubmed
pubmed-article:21207199pubmed:meshHeadingpubmed-meshheading:21207199...lld:pubmed
pubmed-article:21207199pubmed:meshHeadingpubmed-meshheading:21207199...lld:pubmed
pubmed-article:21207199pubmed:meshHeadingpubmed-meshheading:21207199...lld:pubmed
pubmed-article:21207199pubmed:meshHeadingpubmed-meshheading:21207199...lld:pubmed
pubmed-article:21207199pubmed:meshHeadingpubmed-meshheading:21207199...lld:pubmed
pubmed-article:21207199pubmed:meshHeadingpubmed-meshheading:21207199...lld:pubmed
pubmed-article:21207199pubmed:meshHeadingpubmed-meshheading:21207199...lld:pubmed
pubmed-article:21207199pubmed:meshHeadingpubmed-meshheading:21207199...lld:pubmed
pubmed-article:21207199pubmed:meshHeadingpubmed-meshheading:21207199...lld:pubmed
pubmed-article:21207199pubmed:meshHeadingpubmed-meshheading:21207199...lld:pubmed
pubmed-article:21207199pubmed:meshHeadingpubmed-meshheading:21207199...lld:pubmed
pubmed-article:21207199pubmed:meshHeadingpubmed-meshheading:21207199...lld:pubmed
pubmed-article:21207199pubmed:year2011lld:pubmed
pubmed-article:21207199pubmed:articleTitleNovel F-18-labeled PET myocardial perfusion tracers: bench to bedside.lld:pubmed
pubmed-article:21207199pubmed:affiliationNuklearmedizinische Klinik und Poliklinik der Technischen, Universität München, Germany. stephan.nekolla@tum.delld:pubmed
pubmed-article:21207199pubmed:publicationTypeJournal Articlelld:pubmed